TiumBio and Daewon Pharmaceutical Achieve Success with Merigolix in Phase 2 Trial for Uterine Fibroids TiumBio and Daewon Pharmaceutical have successfully completed Phase 2 trials for Merigolix, showing significant reduction in heavy menstrual bleeding for uterine fibroids.

TiumBio and Daewon Pharmaceutical Achieve Success with Merigolix in Phase 2 Trial for Uterine Fibroids #South_Korea #Seongnam #Merigolix #TiumBio #Daewon